{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:57:56Z","timestamp":1764172676591,"version":"3.46.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.7759\/cureus.97862","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:50:57Z","timestamp":1764172257000},"source":"Crossref","is-referenced-by-count":0,"title":["Usual Interstitial Pneumonia and Lung Cancer"],"prefix":"10.7759","author":[{"given":"Lamiyae","family":"Senhaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem","family":"Karhate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abir","family":"Bouhamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounia","family":"Serraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"ElBiaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Chakib","family":"Benjelloun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badreddine","family":"Alami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouchra","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/artpd.1957.76.4.559","article-title":"The association of terminal bronchiolar carcinoma with chronic interstitial inflammation and fibrosis of the lungs","volume":"76","author":"SP DM","year":"1957","unstructured":"SP DM. The association of terminal bronchiolar carcinoma with chronic interstitial inflammation and fibrosis of the lungs. Am Rev Tuberc. 1957, 76:559-66. 10.1164\/artpd.1957.76.4.559","journal-title":"Am Rev Tuberc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1952.00240100045005","article-title":"Acute diffuse interstitial fibrosis of the lungs","volume":"90","author":"Callahan WP Jr","year":"1952","unstructured":"Callahan WP Jr, Sutherland JC, Sutherland JK, Kline JR. Acute diffuse interstitial fibrosis of the lungs. AMA Arch Intern Med. 1952, 90:468-82. 10.1001\/archinte.1952.00240100045005","journal-title":"AMA Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196503)18:3<322::aid-cncr2820180310>3.0.co;2-j","article-title":"Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung","volume":"18","author":"Meyer EC","year":"1965","unstructured":"Meyer EC, Liebow AA. Relationship of interstitial pneumonia honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer. 1965, 18:322-51. 10.1002\/1097-0142(196503)18:3&lt;322::aid-cncr2820180310&gt;3.0.co;2-j","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2017.03.016","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis","volume":"45","author":"Karampitsakos T","year":"2017","unstructured":"Karampitsakos T, Tzilas V, Tringidou R, et al.. Lung cancer in patients with idiopathic pulmonary fibrosis. Pulm Pharmacol Ther. 2017, 45:1-10. 10.1016\/j.pupt.2017.03.016","journal-title":"Pulm Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0359","article-title":"The impact of lung cancer on survival of idiopathic pulmonary fibrosis","volume":"147","author":"Tomassetti S","year":"2015","unstructured":"Tomassetti S, Gurioli C, Ryu JH, et al.. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest. 2015, 147:157-64. 10.1378\/chest.14-0359","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-021-02343-0","article-title":"Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes","volume":"52","author":"Iyoda A","year":"2022","unstructured":"Iyoda A, Azuma Y, Sakamoto S, Homma S, Sano A. Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes. Surg Today. 2022, 52:736-44. 10.1007\/s00595-021-02343-0","journal-title":"Surg Today"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1995.tb03417.x","article-title":"Lung cancer associated with usual interstitial pneumonia","volume":"45","author":"Matsushita H","year":"1995","unstructured":"Matsushita H, Tanaka S, Saiki Y, Hara M, Nakata K, Tanimura S, Banba J. Lung cancer associated with usual interstitial pneumonia. Pathol Int. 1995, 45:925-32. 10.1111\/j.1440-1827.1995.tb03417.x","journal-title":"Pathol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0905-8","article-title":"Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study","volume":"19","author":"Yoo H","year":"2019","unstructured":"Yoo H, Jeong BH, Chung MJ, Lee KS, Kwon OJ, Chung MP. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med. 2019, 19:149. 10.1186\/s12890-019-0905-8","journal-title":"BMC Pulm Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02833-6","article-title":"Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF","volume":"17","author":"Carobene L","year":"2022","unstructured":"Carobene L, Spina D, Disanto MG, et al.. Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF. Intern Emerg Med. 2022, 17:457-64. 10.1007\/s11739-021-02833-6","journal-title":"Intern Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/thx.35.7.496","article-title":"Cryptogenic fibrosing alveolitis and lung cancer","volume":"35","author":"Turner-Warwick M","year":"1980","unstructured":"Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax. 1980, 35:496-9. 10.1136\/thx.35.7.496","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00354-4","article-title":"Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"10","author":"Naccache JM","year":"2022","unstructured":"Naccache JM, Jouneau S, Didier M, et al.. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022, 10:26-34. 10.1016\/S2213-2600(21)00354-4","journal-title":"Lancet Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-014-9664-8","article-title":"Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis","volume":"193","author":"Khan KA","year":"2015","unstructured":"Khan KA, Kennedy MP, Moore E, et al.. Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193:71-7. 10.1007\/s00408-014-9664-8","journal-title":"Lung"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2019-0032","article-title":"Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection","volume":"53","author":"Nezka H","year":"2019","unstructured":"Nezka H, Igor P, Izidor K. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection. Radiol Oncol. 2019, 53:357-61. 10.2478\/raon-2019-0032","journal-title":"Radiol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0605-y","article-title":"Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses","volume":"18","author":"Guyard A","year":"2017","unstructured":"Guyard A, Danel C, Th\u00e9ou-Anton N, et al.. Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses. Respir Res. 2017, 18:120. 10.1186\/s12931-017-0605-y","journal-title":"Respir Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00003613","article-title":"Common pathways in idiopathic pulmonary fibrosis and cancer","volume":"22","author":"Vancheri C","year":"2013","unstructured":"Vancheri C. Common pathways in idiopathic pulmonary fibrosis and cancer. Eur Respir Rev. 2013, 22:265-72. 10.1183\/09059180.00003613","journal-title":"Eur Respir Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)64282-4","article-title":"Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis","volume":"162","author":"Chilosi M","year":"2003","unstructured":"Chilosi M, Poletti V, Zam\u00f2 A, et al.. Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol. 2003, 162:1495-502. 10.1016\/s0002-9440(10)64282-4","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000209","article-title":"Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients","volume":"9","author":"Girard N","year":"2014","unstructured":"Girard N, Marchand-Adam S, Naccache JM, et al.. Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients. J Thorac Oncol. 2014, 9:1162-70. 10.1097\/JTO.0000000000000209","journal-title":"J Thorac Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007843","article-title":"Value of radial probe endobronchial ultrasound-guided transbronchial biopsy and computer tomography-guided transthoracic needle aspiration in the diagnosis of peripheral pulmonary lesions","volume":"96","author":"Zhang Q","year":"2017","unstructured":"Zhang Q, Zhang S, Xu X, Xu Q, Zhou J. Value of radial probe endobronchial ultrasound-guided transbronchial biopsy and computer tomography-guided transthoracic needle aspiration in the diagnosis of peripheral pulmonary lesions. Medicine (Baltimore). 2017, 96:e7843. 10.1097\/MD.0000000000007843","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30478-2","article-title":"Patients with IPF and lung cancer: diagnosis and management","volume":"6","author":"Tzouvelekis A","year":"2018","unstructured":"Tzouvelekis A, Spagnolo P, Bonella F, et al.. Patients with IPF and lung cancer: diagnosis and management. Lancet Respir Med. 2018, 6:86-8. 10.1016\/S2213-2600(17)30478-2","journal-title":"Lancet Respir Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2016.02.001","article-title":"Epidemiology of lung cancer","volume":"25","author":"Mao Y","year":"2016","unstructured":"Mao Y, Yang D, He J, Krasna MJ. Epidemiology of lung cancer. Surg Oncol Clin N Am. 2016, 25:439-45. 10.1016\/j.soc.2016.02.001","journal-title":"Surg Oncol Clin N Am"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2019.06.001","article-title":"Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia","volume":"57","author":"Ogura T","year":"2019","unstructured":"Ogura T, Takigawa N, Tomii K, et al.. Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia. Respir Investig. 2019, 57:512-33. 10.1016\/j.resinv.2019.06.001","journal-title":"Respir Investig"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4132\/KoreanJPathol.2014.48.1.10","article-title":"Usual interstitial pneumonia with lung cancer: clinicopathological analysis of 43 cases","volume":"48","author":"Song DH","year":"2014","unstructured":"Song DH, Choi IH, Ha SY, et al.. Usual interstitial pneumonia with lung cancer: clinicopathological analysis of 43 cases. Korean J Pathol. 2014, 48:10-6. 10.4132\/KoreanJPathol.2014.48.1.10","journal-title":"Korean J Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/00005382-200304000-00002","article-title":"Lung cancer associated with diffuse pulmonary fibrosis: CT-pathologic correlation","volume":"18","author":"Sakai S","year":"2003","unstructured":"Sakai S, Ono M, Nishio T, Kawarada Y, Nagashima A, Toyoshima S. Lung cancer associated with diffuse pulmonary fibrosis: CT-pathologic correlation. J Thorac Imaging. 2003, 18:67-71. 10.1097\/00005382-200304000-00002","journal-title":"J Thorac Imaging"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7516","article-title":"Lung cancer in chronic interstitial pneumonia: early manifestation from serial CT observations","volume":"199","author":"Yoshida R","year":"2012","unstructured":"Yoshida R, Arakawa H, Kaji Y. Lung cancer in chronic interstitial pneumonia: early manifestation from serial CT observations. AJR Am J Roentgenol. 2012, 199:85-90. 10.2214\/AJR.11.7516","journal-title":"AJR Am J Roentgenol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13587","article-title":"Evolving early lung cancers detected during follow-up of idiopathic interstitial pneumonia: serial CT features","volume":"204","author":"Oh SY","year":"2015","unstructured":"Oh SY, Kim MY, Kim JE, Kim SS, Park TS, Kim DS, Choi CM. Evolving early lung cancers detected during follow-up of idiopathic interstitial pneumonia: serial CT features. AJR Am J Roentgenol. 2015, 204:1190-6. 10.2214\/AJR.14.13587","journal-title":"AJR Am J Roentgenol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01347-9","article-title":"Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia","volume":"20","author":"Ogawa K","year":"2020","unstructured":"Ogawa K, Uruga H, Fujii T, et al.. Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia. BMC Pulm Med. 2020, 20:307. 10.1186\/s12890-020-01347-9","journal-title":"BMC Pulm Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.07.034","article-title":"Clinicopathological, immunohistochemical, and genetic features of primary lung adenocarcinoma occurring in the setting of usual interstitial pneumonia pattern","volume":"11","author":"Masai K","year":"2016","unstructured":"Masai K, Tsuta K, Motoi N, et al.. Clinicopathological, immunohistochemical, and genetic features of primary lung adenocarcinoma occurring in the setting of usual interstitial pneumonia pattern. J Thorac Oncol. 2016, 11:2141-9. 10.1016\/j.jtho.2016.07.034","journal-title":"J Thorac Oncol"},{"key":"ref28","article-title":"[Clinical Practice Guideline: Diagnosis and Therapeutic Management of Idiopathic Pulmonary Fibrosis in Adults]","author":"Tunisian Society of Respiratory Diseases and Allergology (STMRA)","year":"2023","unstructured":"Tunisian Society of Respiratory Diseases and Allergology (STMRA). [Clinical Practice Guideline: Diagnosis and Therapeutic Management of Idiopathic Pulmonary Fibrosis in Adults]. Tunisian Society of Respiratory Diseases and Allergology (STMRA), Tunisia; 2023."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000574","article-title":"The ATS\/ERS\/JRS\/ALAT statement \"IPF by HRCT\" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer","volume":"103","author":"Asai N","year":"2017","unstructured":"Asai N, Katsuda E, Hamanaka R, et al.. The ATS\/ERS\/JRS\/ALAT statement \"IPF by HRCT\" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer. Tumori. 2017, 103:60-5. 10.5301\/tj.5000574","journal-title":"Tumori"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001529","article-title":"Lung cancer resection in patients with underlying usual interstitial pneumonia: a meta-analysis","volume":"10","author":"Patel AJ","year":"2023","unstructured":"Patel AJ, Walters GI, Watkins S, et al.. Lung cancer resection in patients with underlying usual interstitial pneumonia: a meta-analysis. BMJ Open Respir Res. 2023, 10:e001529. 10.1136\/bmjresp-2022-001529","journal-title":"BMJ Open Respir Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.09.050","article-title":"Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer","volume":"147","author":"Sato T","year":"2014","unstructured":"Sato T, Teramukai S, Kondo H, et al.. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014, 147:1604-11.e3. 10.1016\/j.jtcvs.2013.09.050","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-014-0487-6","article-title":"A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients","volume":"63","author":"Sato T","year":"2015","unstructured":"Sato T, Kondo H, Watanabe A, et al.. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015, 63:164-72. 10.1007\/s11748-014-0487-6","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318216ee6b","article-title":"The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer","volume":"6","author":"Kenmotsu H","year":"2011","unstructured":"Kenmotsu H, Naito T, Kimura M, et al.. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol. 2011, 6:1242-6. 10.1097\/JTO.0b013e318216ee6b","journal-title":"J Thorac Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1250688","article-title":"Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis","volume":"13","author":"Wang Z","year":"2023","unstructured":"Wang Z, Bai J, Liu Y, Li P, Jiao G. Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis. Front Oncol. 2023, 13:1250688. 10.3389\/fonc.2023.1250688","journal-title":"Front Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00380-2022","article-title":"Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial","volume":"60","author":"Otsubo K","year":"2022","unstructured":"Otsubo K, Kishimoto J, Ando M, et al.. Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial. Eur Respir J. 2022, 60:2200380. 10.1183\/13993003.00380-2022","journal-title":"Eur Respir J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14217","article-title":"Phase II study of nab-paclitaxel\u00a0+\u00a0carboplatin for patients with non-small-cell lung cancer and interstitial lung disease","volume":"110","author":"Kenmotsu H","year":"2019","unstructured":"Kenmotsu H, Yoh K, Mori K, et al.. Phase II study of nab-paclitaxel\u00a0+\u00a0carboplatin for patients with non-small-cell lung cancer and interstitial lung disease. Cancer Sci. 2019, 110:3738-45. 10.1111\/cas.14217","journal-title":"Cancer Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-22-162","article-title":"Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Matsumoto K","year":"2022","unstructured":"Matsumoto K, Shiroyama T, Kuge T, et al.. Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies. Transl Lung Cancer Res. 2022, 11:1835-46. 10.21037\/tlcr-22-162","journal-title":"Transl Lung Cancer Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7150\/jca.24936","article-title":"Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage III non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy","volume":"9","author":"Kobayashi H","year":"2018","unstructured":"Kobayashi H, Naito T, Omae K, et al.. Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage III non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy. J Cancer. 2018, 9:2054-60. 10.7150\/jca.24936","journal-title":"J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423748-usual-interstitial-pneumonia-and-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:50:57Z","timestamp":1764172257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423748-usual-interstitial-pneumonia-and-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.97862","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}